Tanke Biosciences Corporation (TNBI)
USD 0.02
(33.33%)
USD 0.02
(33.33%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2012 |
|---|---|---|---|---|---|---|
| Revenue | - | - | - | - | - | 28.56 Million |
| Cost of Revenue | 8500.00 | - | - | - | - | 18.61 Million |
| Gross Profit | -8500.00 | - | - | - | - | 9.94 Million |
| Operating Expenses | 85.66 Thousand | 128.17 Thousand | 668.03 Thousand | - | - | 5.41 Million |
| Selling, General and Administrative Expenses | 85.66 Thousand | 128.17 Thousand | 668.03 Thousand | - | - | 5.25 Million |
| Research and Development Expenses | - | - | - | - | - | 290.83 Thousand |
| Other Expenses | - | - | - | - | - | - |
| Cost and Expenses | 94.16 Thousand | 128.17 Thousand | 668.03 Thousand | - | - | 24.03 Million |
| Operating Income | -94.16 Thousand | -128.17 Thousand | -668.03 Thousand | - | - | 4.53 Million |
| Interest Expense | 55.77 Thousand | 55.58 Thousand | 1935.00 | - | - | 1.44 Million |
| Income Tax Expense | -82.52 Thousand | -128.18 | -668.03 | - | - | 831.59 Thousand |
| Earnings before Tax | -82.52 Thousand | -98.15 Thousand | -722.98 Thousand | - | - | 602.59 Thousand |
| Net Income | -82.52 Thousand | -98.15 Thousand | -722.98 Thousand | - | - | -210.24 Thousand |
| Earnings Per Share Basic | -0.00 | -0.01 | -0.06 | - | - | -0.02 |
| Earnings Per Share Diluted | -0.00 | -0.01 | -0.06 | - | - | -0.02 |
| Weighted Average Shares Outstanding | 21.11 Million | 12.47 Million | 12.74 Million | 13.32 Million | 13.32 Million | 13.32 Million |
| Weighted Average Shares Outstanding (Diluted) | 21.11 Million | 12.47 Million | 12.74 Million | 13.32 Million | 13.32 Million | 13.32 Million |
| Gross Margin | - | - | - | - | - | 0.35 |
| EBIT Margin | - | - | - | - | - | 0.19 |
| Profit Margin | - | - | - | - | - | -0.01 |
| EBITDA | -18.25 Thousand | 30.02 Thousand | -54.95 Thousand | - | - | 5.46 Million |
| Earnings Before Tax Margin | - | - | - | - | - | 0.16 |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Revenue | - | - | - | - | - | - |
| Cost of Revenue | 196.00 | - | 8500.00 | - | 8304.00 | - |
| Gross Profit | -196.00 | - | -8500.00 | - | -8304.00 | - |
| Operating Expenses | 1867.00 | 48.98 Thousand | 85.66 Thousand | 19.71 Thousand | 11.68 Thousand | 15.52 Thousand |
| Selling, General and Administrative Expenses | 1867.00 | 48.98 Thousand | - | 19.71 Thousand | 11.68 Thousand | 15.52 Thousand |
| Research and Development Expenses | - | - | - | - | - | - |
| Other Expenses | - | - | - | - | - | - |
| Cost and Expenses | 2063.00 | 48.98 Thousand | 94.16 Thousand | 19.71 Thousand | 19.99 Thousand | 15.52 Thousand |
| Operating Income | -2063.00 | -48.99 Thousand | -94.16 Thousand | -19.71 Thousand | -19.99 Thousand | -15.53 Thousand |
| Interest Expense | - | - | 55.77 Thousand | 2209.00 | 41.8 Thousand | 45.00 |
| Income Tax Expense | - | -43.27 Thousand | - | -43.81 Thousand | -4.00 | -122.08 Thousand |
| Earnings before Tax | -2063.00 | -37.71 Thousand | -82.52 Thousand | -30.42 Thousand | 9289.00 | -15.57 Thousand |
| Net Income | -2063.00 | -37.71 Thousand | -82.52 Thousand | -30.42 Thousand | 9289.00 | -15.57 Thousand |
| Earnings Per Share Basic | -0.00 | -0.00 | - | -0.00 | 0.00 | -0.00 |
| Earnings Per Share Diluted | -0.00 | -0.00 | - | -0.00 | 0.00 | -0.00 |
| Weighted Average Shares Outstanding | 21.83 Million | 21.83 Million | 21.11 Million | 21.11 Million | 21.11 Million | 21.11 Million |
| Weighted Average Shares Outstanding (Diluted) | 21.83 Million | 21.83 Million | 21.11 Million | 21.11 Million | 21.11 Million | 21.11 Million |
| Gross Margin | - | - | - | - | - | - |
| EBIT Margin | - | - | - | - | - | - |
| Profit Margin | - | - | - | - | - | - |
| EBITDA | -1867.00 | -48.99 Thousand | - | -19.71 Thousand | -11.69 Thousand | -15.53 Thousand |
| Earnings Before Tax Margin | - | - | - | - | - | - |
BSBK
5234
SIM
ONWARDTEC
AIAENG
6435